Every year, millions of patients worldwide participate in randomized clinical trials hoping to benefit from an experimental treatment or potentially help someone else with the same condition. However, rules and regulations are becoming a menace to academic clinical trials where resources are limited and risks may be much less than those associated with new experimental drugs. "There is no question that research participants need protection," write Paul Hébert, Editor-in-Chief, CMAJ, and coauthors...
More...
More...